Skip to content

Checked

Class IIDrug recallOngoing

Levetiracetam Oral Solution recall

Recalled by Akorn, Inc. of Gurnee, IL · FDA report 06/07/2023

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
04/26/2023
Distribution
Nationwide

Reason for recall

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Levetiracetam Oral Solution 100 mg/mL (100 mg/mL), 473 mL, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031. ALL NDCs
Lot and code info
All Lots
Recall number
D-0816-2023
Event ID
91788
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA and Puerto Rico

Recall timeline

  1. 04/26/2023Firm started the recall
  2. 06/01/2023FDA classified it as Class II
  3. 06/07/2023Published in the FDA enforcement report

All products in this recall

86 products under event 91788

More recalls from Akorn

Frequently asked questions

Why was Levetiracetam Oral Solution recalled?
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide in the USA and Puerto Rico
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 06/07/2023 · Do not rely on openFDA to make decisions regarding medical care